LifeVantage Co. (NASDAQ:LFVN – Get Free Report)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.42 and traded as low as $6.03. LifeVantage shares last traded at $6.05, with a volume of 42,786 shares changing hands.
LifeVantage Stock Performance
The firm has a market cap of $77.86 million, a P/E ratio of 26.30 and a beta of 0.78. The business’s fifty day moving average is $6.60 and its 200-day moving average is $6.42.
LifeVantage (NASDAQ:LFVN – Get Free Report) last released its quarterly earnings results on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. LifeVantage had a net margin of 1.40% and a return on equity of 19.96%. The firm had revenue of $51.62 million during the quarter.
LifeVantage Dividend Announcement
Hedge Funds Weigh In On LifeVantage
A hedge fund recently raised its stake in LifeVantage stock. Ritholtz Wealth Management grew its position in shares of LifeVantage Co. (NASDAQ:LFVN – Free Report) by 23.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,027 shares of the company’s stock after purchasing an additional 4,756 shares during the quarter. Ritholtz Wealth Management owned about 0.20% of LifeVantage worth $150,000 as of its most recent SEC filing. 35.32% of the stock is currently owned by institutional investors.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Articles
- Five stocks we like better than LifeVantage
- How to Use the MarketBeat Excel Dividend Calculator
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Dividend Capture Strategy: What You Need to Know
- Merger or Not, Albertson’s Companies is a Good Buy
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.